4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrazole

Catalog No. :
ACOTFN254
CAS No. :
1391835-53-2
Molecular Formula :
C16H21BN2O4S
Molecular Weight :
348.23

IUPAC Name:4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrazole

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$349.00Login to see priceInquiryInquiry
1g95%$818.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrazole
IUPAC Name4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrazole
MDL No.MFCD22571831
Molecular FormulaC16H21BN2O4S
Molecular Weight348.23
SMILESO=S(N1N=CC(B2OC(C)(C)C(C)(C)O2)=C1)(C3=CC=C(C)C=C3)=O
InChI KeyAMHSMPPRQCGVEY-UHFFFAOYSA-N
Synonym4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrazole;1H-Pyrazole, 1-[(4-methylphenyl)sulfonyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1391835-53-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOTFN254 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYUSO179 route compound structure diagram
    ACYUSO179269410-08-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOTFN254 route product structure diagram
    ACOTFN2541391835-53-2
Inquiry

2. ACOTFN254 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACYOCP361 route compound structure diagram
    ACYOCP361116228-41-2 In Stock
  4. Then
  5. ACOTFN254 route product structure diagram
    ACOTFN2541391835-53-2
Inquiry

Comments (0)